Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?
Ali Hamady, JinJu Lee, Zuzanna Loboda
Infection (2021) Vol. 50, Iss. 1, pp. 11-25
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
Daniel R. Feikin, Melissa M. Higdon, Laith J. Abu‐Raddad, et al.
The Lancet (2022) Vol. 399, Iss. 10328, pp. 924-944
Open Access | Times Cited: 1082
SARS-CoV-2 infections in children: Understanding diverse outcomes
Petter Brodin
Immunity (2022) Vol. 55, Iss. 2, pp. 201-209
Open Access | Times Cited: 103
Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial
Raburn M. Mallory, Neil Formica, Susan Pfeiffer, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 11, pp. 1565-1576
Open Access | Times Cited: 66
Reported Adverse Effects and Attitudes among Arab Populations Following COVID-19 Vaccination: A Large-Scale Multinational Study Implementing Machine Learning Tools in Predicting Post-Vaccination Adverse Effects Based on Predisposing Factors
Ma’mon M. Hatmal, Mohammad A. I. Al-Hatamleh, Amin N. Olaimat, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 366-366
Open Access | Times Cited: 59
Psychological distress, depression, anxiety, and life satisfaction following COVID-19 infection: evidence from 11 UK longitudinal population studies
Ellen J. Thompson, Jean Stafford, Bettina Moltrecht, et al.
The Lancet Psychiatry (2022) Vol. 9, Iss. 11, pp. 894-906
Open Access | Times Cited: 59
Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection
Behnam Keshavarz, Nathan E. Richards, Lisa J. Workman, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Role of the humoral immune response during COVID-19: guilty or not guilty?
Melyssa Yaugel-Novoa, Thomas Bourlet, Stéphane Paul
Mucosal Immunology (2022) Vol. 15, Iss. 6, pp. 1170-1180
Open Access | Times Cited: 38
Duration of Effectiveness of Vaccines Against SARS-CoV-2 Infection and COVID-19 Disease: Results of a Systematic Review and Meta-Regression
Daniel R. Feikin, Melissa M. Higdon, Laith J. Abu‐Raddad, et al.
SSRN Electronic Journal (2021)
Open Access | Times Cited: 50
Immunogenicity and Safety of Homologous and Heterologous Prime–Boost Immunization with COVID-19 Vaccine: Systematic Review and Meta-Analysis
Haoyue Cheng, Zhicheng Peng, Shuting Si, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 798-798
Open Access | Times Cited: 31
Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis
Shiyao Xu, Jincheng Li, Hongyuan Wang, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
SARS-CoV-2 seropositivity amongst healthcare workers in South Africa during the Omicron wave: natural infection versus vaccination
Daniel Hoffmann, Pieter Meyer, Catherine M. Worsley, et al.
Journal of Clinical Pathology (2025), pp. jcp-209722
Closed Access
Robust COVID-19 Vaccine Responses Despite Filarial Co-Infection: Insights from a Lymphatic Filariasis Cohort in Ghana
Julia Meyer, Jennifer Nadal, Linda Batsa Debrah, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 312-312
Open Access
Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel
Vivian Glück, Sonja Grobecker, Josef Köstler, et al.
Infection (2021) Vol. 50, Iss. 2, pp. 439-446
Open Access | Times Cited: 36
SARS-CoV-2 Spike and Neutralizing Antibody Kinetics 90 Days after Three Doses of BNT162b2 mRNA COVID-19 Vaccine in Singapore
Chin Shern Lau, Soon Kieng Phua, Ya Li Liang, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 331-331
Open Access | Times Cited: 23
Immunogenicity and Safety Following a Homologous Booster Dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): A Phase 2 Randomized Placebo-Controlled Trial
Raburn M. Mallory, Neil Formica, Susan Pfeiffer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 28
Immunogenicity and safety of heterologous boost immunization with PastoCovac Plus against COVID-19 in ChAdOx1-S or BBIBP-CorV primed individuals
Sana Eybpoosh, Alireza Biglari, Rahim Sorouri, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011744-e1011744
Open Access | Times Cited: 11
Assessing the potential impact of immunity waning on the dynamics of COVID-19 in South Africa: an endemic model of COVID-19
Musa Rabiu, Sarafa A. Iyaniwura
Nonlinear Dynamics (2022) Vol. 109, Iss. 1, pp. 203-223
Open Access | Times Cited: 17
Rapid quantitation of SARS-CoV-2 antibodies in clinical samples with an electrochemical sensor
Sharma T. Sanjay, Nolan Durr, Pawan Jolly, et al.
Biosensors and Bioelectronics (2022) Vol. 223, pp. 115037-115037
Open Access | Times Cited: 17
Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection
Irène A. Abela, Magdalena Schwarzmüller, Agnė Ulytė, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 2
Association between Gut Microbiota Composition and Long-Term Vaccine Immunogenicity following Three Doses of CoronaVac
Lina Zhang, Jing Tong Tan, Ho Yu Ng, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 365-365
Open Access | Times Cited: 2
Asymmetric Mach–Zehnder Interferometric Biosensing for Quantitative and Sensitive Multiplex Detection of Anti-SARS-CoV-2 Antibodies in Human Plasma
G.A.J. Besselink, Anke Schütz-Trilling, Janneke Veerbeek, et al.
Biosensors (2022) Vol. 12, Iss. 8, pp. 553-553
Open Access | Times Cited: 12
Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4+ T-cell response with pre-primed responses directed against common cold coronaviruses
Tim Westphal, Maria Mader, Hendrik Karsten, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Anti‐SARS‐CoV‐2 IgG antibody levels among Thai healthcare providers receiving homologous and heterologous COVID‐19 vaccination regimens
Wanitchaya Kittikraisak, Taweewun Hunsawong, Somsak Punjasamanvong, et al.
Influenza and Other Respiratory Viruses (2022) Vol. 16, Iss. 4, pp. 662-672
Open Access | Times Cited: 10
Design and performance characteristics of the Elecsys anti-SARS-CoV-2 S assay
Karin Taffertshofer, Mirko Walter, Peter Mackeben, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Contributions of vibrational spectroscopy to virology: A review
Iqra Ishtiaq Chaudhary, Naomi Jackson, Denise Denning, et al.
Clinical Spectroscopy (2022) Vol. 4, pp. 100022-100022
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top